Holen Sie sich die Stockscreener-App
71.53
18.81%
10.80
Metsera Inc Aktie (MTSR) Neueste Nachrichten
Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer - MSN
Pfizer & Novo boost Metsera bids, Hertz stock skyrockets - Yahoo Finance
Metsera Inc Declares Novo Nordisk Proposal Superior - TradingView
Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger - MarketScreener
Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion - Investor's Business Daily
Novo Nordisk (NVO) Extends Enhanced Acquisition Offer for Metser - GuruFocus
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera - Reuters
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera By Reuters - Investing.com
/C O R R E C T I O N -- Metsera, Inc./ - Placera.se
Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight - Reuters
Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle - Bloomberg.com
NVO's Acquisition Offer Values Metsera at $10B - GuruFocus
Novo, Pfizer's bidding war heats up with supercharged offers for Metsera - Fierce Biotech
Pfizer, Novo Nordisk improve offers for Metsera as bidding war escalates - Capital Brief
Metsera, Inc. Stock Soars Amid Acquisition Drama - TipRanks
Metsera Receives Amended Proposal from Novo Nordisk - citybiz
Novo Nordisk (NVO) Offers Enhanced Proposal to Metsera - GuruFocus
Novo Nordisk and Pfizer sweeten bids for Metsera - Axios
Metsera stock soars as Novo Nordisk, Pfizer sweeten bids in takeover battle - Investing.com
Novo Nordisk Sweetens Offer for Metsera - The Wall Street Journal
Pfizer Boosts Profit View While Chasing Obesity Startup Metsera - Bloomberg.com
Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates - statnews.com
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters - Stocktwits
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer - CNBC
Novo Nordisk submits updated proposal to acquire Metsera, Inc. - The Manila Times
Both Novo Nordisk and Pfizer have adjusted their bids for Metsera. - MarketScreener
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up By Reuters - Investing.com
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up - MarketScreener
Novo Nordisk values Metsera at $86.20 per share in takeover bid - Investing.com
Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion - Yahoo! Finance UK
Pfizer Q3 Results Signal Shift From Covid Windfall to Obesity-Driven Growth Path - Investing.com
Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies - Financial Times
Legal battle erupts between Pfizer and Novo Nordisk for Metsera - Benefits and Pensions Monitor
With new bids in hand, Metsera declares Novo's $10B offer better than Pfizer's - FirstWord Pharma
Novo CEO on new accusations from Pfizer in Metsera dispute: “Absurd and not based on facts" - medwatch.com
Metsera opposes Pfizer motion for restraining order against Novo Nordisk bid - MLex
Pfizer reports earnings beat and boosts guidance as Metsera bid-off heats up - Sherwood News
Pfizer Raises 2025 Profit Forecast Before Heading to Court Over Metsera Deal - US News Money
Why Metsera Inc. stock appeals to analystsEarnings Overview Report & Capital Efficiency Focused Strategies - newser.com
Pfizer (PFE) Stock: Company Files Lawsuits Against Novo Nordisk Over $7 Billion Metsera Deal - CoinCentral
Pfizer sues rival, accuses Novo of using US$9b Metsera bid to stall new obesity drug - Malay Mail
Five things for pharma marketers to know for Tuesday, November 4, 2025 - Medical Marketing and Media
Metsera Inc. stock chart pattern explainedWeekly Stock Recap & Real-Time Volume Analysis - newser.com
Novo Nordisk Challenges Pfizer’s Bid for Metsera Amid FDA Leadership Shake-Up - geneonline.com
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
Tools to monitor Metsera Inc. recovery probabilityWeekly Earnings Recap & Technical Entry and Exit Alerts - newser.com
Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit - Reuters
Is Metsera Inc. stock a safe investment in uncertain marketsWatch List & AI Driven Stock Price Forecasts - newser.com
Key facts: Novo Nordisk Q3 revenue up 9.4%; bids $8.5B for Metsera; Hims launches semaglutide - TradingView
Why Pfizer Can Still Prevail in the Obesity Fight With Novo NordiskWSJ - The Wall Street Journal
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war - Pharmaceutical Technology
Pfizer’s And Novo’s Competing Bids For Metsera Devolve Into Lawsuits, Name Calling - Citeline News & Insights
ACQUISITIONS & MERGERS NEWS: Pfizer sues Metsera and Novo Nordisk to halt their proposed merger - VitalLaw.com
Pfizer, Novo's Metsera war could redraw the map for obesity treatments - Axios
Pfizer Hits Novo Nordisk In Fed. Court Over $9B Metsera Deal - Law360
Metsera, Inc. Responds to Pfizer’s Litigation Claims - MSN
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo - Investor's Business Daily
Pfizer Sues Novo, Metsera for Second Time in Brewing Deal War - Bloomberg.com
Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal - MedCity News
Market Voices: Pfizer-Novo Nordisk legal battle; Trump on Zhao pardon - MSN
Pfizer Files Lawsuits Against Metsera and Novo Nordisk - Pharmaceutical Executive
Coinbase Said Web3 - Bloomberg.com
Pfizer sues to block Novo Nordisk bid for obesity drug maker Metsera - The Business Journals
1.68%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):